Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals

References

• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235–49.
   PubMed Web of Science ®Google Scholar
• Hywel D, Williams NLT, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev 2013;65:315–499.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Muller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129–39.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–66.
   PubMed Web of Science ®Google Scholar
• Dave RH, Shah DA, Patel PG. Development and evaluation of high loading oral dissolving film of aspirin and acetaminophen. J Pharm Sci Pharmacol 2014;1:112–22.
   Google Scholar
• Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm 2011;413:237–44.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–20.
   PubMed Web of Science ®Google Scholar
• Murdande SB, Shah DA, Dave RH. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals. J Pharm Sci 2015;104:2094–102.
   PubMed Web of Science ®Google Scholar
• Shah DA, Murdande SB, Dave RH. A review: pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions. J Pharm Sci 2016;105:10–24.
   PubMed Web of Science ®Google Scholar
• Kumar S, Jog R, Shen J, et al. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders. Pharm Res 2015;32:1694–703.
   PubMed Web of Science ®Google Scholar
• Song J, Wang Y, Song Y, et al. Development and characterisation of ursolic acid nanocrystals without stabilizer having improved dissolution rate and in vitro anticancer activity. AAPS PharmSciTech 2014;15:11–9.
   PubMed Web of Science ®Google Scholar
• Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–37.
   Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–96.
   PubMed Web of Science ®Google Scholar
• Cooper ER. Nanoparticles: a personal experience for formulating poorly water soluble drugs. J Control Release 2010;141:300–2.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Vermant J, Martens JA, et al. Solubility increases associated with crystalline drug nanoparticles: methodologies and significance. Mol Pharm 2010;7:1858–70.
   PubMed Web of Science ®Google Scholar
• Anhalt K, Geissler S, Harms M, et al. Development of a new method to assess nanocrystal dissolution based on light scattering. Pharm Res 2012;29:2887–901.
   PubMed Web of Science ®Google Scholar
• Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011;409:260–8.
   PubMed Web of Science ®Google Scholar
• Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res 2008;25:2302–8.
   PubMed Web of Science ®Google Scholar
• Zuo B, Sun Y, Li H, et al. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals. Int J Pharm 2013;455:267–75.
   PubMed Web of Science ®Google Scholar
• Isa L, Lucas F, Wepf R, Reimhult E. Measuring single-nanoparticle wetting properties by freeze-fracture shadow-casting cryo-scanning electron microscopy. Nat Commun 2011;2:438. doi:10.1038/ncomms1441.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Froyen L, Van Humbeeck J, et al. Drying of crystalline drug nanosuspensions – the importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur J Pharm Sci 2008;35:127–35.
   PubMed Web of Science ®Google Scholar
• Beck C, Sievens-Figueroa L, Gärtner K, et al. Effects of stabilizers on particle redispersion and dissolution from polymer strip films containing liquid antisolvent precipitated griseofulvin particles. Powder Technol 2013;236:37–51.
   Web of Science ®Google Scholar
• Hu J, Ng WK, Dong Y, et al. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm 2011;404:198–204.
   PubMed Web of Science ®Google Scholar
• Niwa T, Danjo K. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs. Eur J Pharm Sci 2013;50:272–81.
   PubMed Web of Science ®Google Scholar
• Bojnanska E, Kalina M, Parizek L, et al. Determination of critical parameters of drug substance influencing dissolution: a case study. BioMed Res Int 2014;2014. doi:http://dx.doi.org/10.1155/2014/929248.
   PubMed Web of Science ®Google Scholar
• Sahoo NG, Kakran M, Shaal LA, et al. Preparation and characterization of quercetin nanocrystals. J Pharm Sci 2011;100:2379–90.
   PubMed Web of Science ®Google Scholar
• Okoye PC. To systemically characterize magnesium stearate polymorphs and practically evaluate their effect on physicochemical properties of naproxen (BCS Class II) and acetaminophen (BCS Class III) as model drugs. Edited by Pharmaceutical Sciences. Brooklyn (NY): Long Island University;2013:190.
   Google Scholar
• Prajapati H, Dalrymple DM, Serajuddin AT. In vitro dispersion test can serve as a predictive method for assessing performance of lipid-based drug delivery systems. J Excipient Food Chem 2013;4:111–25.
   Google Scholar
• Sun J, Wang F, Sui Y, et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q(10) as naked nanocrystals. Int J Nanomed 2012;7:5733–44.
   PubMed Web of Science ®Google Scholar
• Chidambaram N, Burgess DJ. A novel in vitro release method for submicron-sized dispersed systems. AAPS PharmSci 1999;1:32–40
   Google Scholar
• Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm 2006;312:179–86.
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 2006;111:56–64.
   PubMed Web of Science ®Google Scholar
• Ma Q, Sun H, Che E, et al. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: Influence of particle size and crystalline state. Int J Pharm 2013;441:75–81.
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 1995;125:91–7.
   Web of Science ®Google Scholar
• Korang-Yeboah M, Rahman Z, Shah D, et al. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations. Int J Pharm 2016;499:20–8.
   PubMed Web of Science ®Google Scholar
• Wu W, Nancollas G. A new understanding of the relationship between solubility and particle size. J Solut Chem 1998;27:521–31.
   Web of Science ®Google Scholar
• Kaur J, Aggarwal G, Singh G, Rana AC. Improvement of drug soluility using solid dispersion. Int J Pharm Pharm Sci 2012;4:47–53
   Google Scholar
• Li X, Vogt FG, Hayes D, Mansour HM. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers. J Aeros Med Pulm Drug Deliv 2014;27:81–93.
   PubMed Web of Science ®Google Scholar
• Crisp MT, Tucker CJ, Rogers TL, et al. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J Control Release 2007;117:351–9.
   PubMed Web of Science ®Google Scholar
• Heng D, Cutler DJ, Chan HK, et al. What is a suitable dissolution method for drug nanoparticles? Pharm Res 2008;25:1696–701.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Itsubata S, Masaoka Y, et al. In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it. Biol Pharm Bull 2011;34:401–7.
   PubMed Web of Science ®Google Scholar
• Shekunov BY, Chattopadhyay P, Seitzinger J, Huff R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res 2006;23:196–204.
   PubMed Web of Science ®Google Scholar